Company page

Meiragtx Holdings Plc

Meiragtx Holdings Plc is a public company traded under the ticker MGTX in the American market. With a market capitalization of approximately $1.09 billion, the company focuses on developing innovative gene therapies. Meiragtx aims to address unmet medical needs through its advanced research and development efforts.